Enhancing Communication about Paediatric Medicines: Lessons from a Qualitative Study of Parents’ Experiences of Their Child’s Suspected Adverse Drug Reaction

Authors: Janine Arnott, Hannah Hesselgreaves, Anthony J. Nunn, Matthew Peak, Munir Pirmohamed, Rosalind L. Smyth, Mark A. Turner, Bridget Young

DOI: 10.1371/journal.pone.0046022

Abstract Summary

Parents of children experiencing adverse drug reactions often felt dissatisfied with clinician communication and unclear about future medication use. Some even refused further treatment due to fear. However, parents of children with cancer reported better experiences when clinicians proactively explained medication risks upfront. The study suggests improved communication is needed, with prospective risk discussions at prescription time proving most effective.

Why Brain? 🧠

Study reveals parents often feel poorly informed about their child’s adverse drug reactions and future medication safety, but proactive communication at prescription time—as seen in pediatric oncology—improves understanding.

The image is AI-generated for illustrative purposes only. Courtesy of Midjourney.